• R Deshayes, M Eustache, A Moreau, P Péterlin, A Néel, A Masseau, C Bodet-Milin, and M Hamidou.
• Service de médecine interne, Hôtel-Dieu, Nantes 44000, France. Electronic address: Deshayesrobin@hotmail.fr.
• Rev Med Interne. 2021 Apr 1; 42 (4): 281-284.

IntroductionWe report an original observation of multifocal refractory Destombes-Rosai-Dorfman disease associated with a myelodysplastic syndrome. The treatment of myelodysplasia allowed a good and prolonged response of both pathologies.Case ReportA 35-year-old patient was investigated for bilateral exophthalmia, histologically related to Destombes-Rosai-Dorfman disease. The extension workup showed sinus, kidney and lymph node involvement. It was treated unsuccessfully with corticosteroids, colchicine, methotrexate, infliximab, cladribine and tociluzimab. The secondary appearance of myelodysplasia (AREB IPSS score intermediate-2) led to induction treatment with aracytin and idarubicin, and maintenance with azacytidine for 2 years. With 5 years of follow-up, the patient is in remission both of the myelodysplastic syndrome and Destombes-Rosai-Dorfman disease.ConclusionOur observation discusses the interest of the treatment of myelodysplastic syndrome for the management of associated extra-hematological manifestations.Copyright © 2021 Société Nationale Française de Médecine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.

16 keywords...

hide…